Omega-3 fatty acids, inflammation and angiogenesis: Basic mechanisms behind the cardioprotective effects of fish and fish oils

Cellular and Molecular Biology

Volumn 56, Issue 1, 2010, Pages 59-82

  Massaro, M ^a,b   Scoditti, E ^a,b   Carluccio, M A ^a,b   Campana, M C ^a,b   De Caterina, R ^a,c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Adhesion molecules; Atherosclerosis; Cyclooxygenase 2; Endothelial activation; Endothelium; n 3 fatty acids; Omega 3 fatty acids; Plaque angiogenesis; Plaque rupture

Indexed keywords

CELL ADHESION MOLECULE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; FENOFIBRATE; FISH OIL; GEMFIBROZIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; LINOLENIC ACID; LIPOXYGENASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; PROSTANOID; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; VASCULOTROPIN; CYCLOOXYGENASE 2;

ANGIOGENESIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY BYPASS SURGERY; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FATTY ACID METABOLISM; FISH; GENE EXPRESSION; HEART PROTECTION; HUMAN; INFLAMMATION; NUTRIGENOMICS; TRANSCRIPTION INITIATION; VASA VASORUM; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); REVIEW; SIGNAL TRANSDUCTION;

ATHEROSCLEROSIS; CELL ADHESION MOLECULES; CYCLOOXYGENASE 2; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 77953627048     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T880     Document Type: Article

References (176)

1. Ait-Said F., Elalamy I., Werts C., Gomard M. T., Jacquemin C., Couetil J. P. and Hatmi M. Inhibition by eicosapentaenoic acid of IL-1beta-induced PGHS-2 expression in human microvascular endothelial cells: involvement of lipoxygenase-derived metabolites and p38 MAPK pathway. Biochim Biophys Acta 2003;1631(1):77-84.
2. Albert C. M., Campos H., Stampfer M. J., Ridker P. M., Manson J. E., Willett W. C. and Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346(15):1113-1118.
3. Ambring A., Johansson M., Axelsen M., Gan L., Strandvik B. and Friberg P. Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. Am J Clin Nutr 2006;83(3):575-581.
4. Arico S., Pattingre S., Bauvy C., Gane P., Barbat A., Codogno P. and Ogier-Denis E. Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. J Biol Chem 2002;277(31):27613-27621.
5. Ascherio A., Rimm E. B., Stampfer M. J., Giovannucci E. L. and Willett W. C. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995;332:977-982.
6. Bagga D., Wang L., Farias-Eisner R., Glaspy J. A. and Reddy S. T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003;100(4):1751-1756. Epub 2003 Feb 1710.
7. Barger A. C., Beeuwkes R., 3rd, Lainey L. L. and Silverman K. J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310(3):175-177.
8. Barker S. G., Talbert A., Cottam S., Baskerville P. A. and Martin J. F. Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler Thromb 1993;13(1):70-77.
9. Bea F., Blessing E., Bennett B. J., Kuo C. C., Campbell L. A., Kreuzer J. and Rosenfeld M. E. Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Cardiovasc Res 2003;60(1):198-204.
10. Bjornheden T., Levin M., Evaldsson M. and Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 1999;19(4):870-876.
11. Bochkov V. N., Philippova M., Oskolkova O., Kadl A., Furnkranz A., Karabeg E., Afonyushkin T., Gruber F., Breuss J., Minchenko A., Mechtcheriakova D., Hohensinner P., Rychli K., Wojta J., Resink T., Erne P., Binder B. R. and Leitinger N. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ Res 2006;99(8):900-908.
12. Bonn D. Blocking angiogenesis in diabetic retinopathy. Lancet 1996;348(9027):604.
13. Braissant O., Foufelle F., Scotto C., Dauca M. and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996;137(1):354-366.
14. Burdge G. Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 2004;7(2):137-144.
15. Burdge G. C. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot Essent Fatty Acids 2006;75(3):161-168.
16. Burdge G. C., Jones A. E. and Wootton S. A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men*. Br J Nutr 2002;88(4):355-363.
17. Burleigh M. E., Babaev V. R., Oates J. A., Harris R. C., Gautam S., Riendeau D., Marnett L. J., Morrow J. D., Fazio S. and Linton M. F. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 2002;105(15):1816-1823.
18. Burleigh M. E., Babaev V. R., Yancey P. G., Major A. S., McCaleb J. L., Oates J. A., Morrow J. D., Fazio S. and Linton M. F. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. J Mol Cell Cardiol 2005;21:21.
19. Burr G. and Burr M. On the nature of fatty acids essential in nutrition. J Biol Chem 1930;86:345-367.
20. Burr G. O. and Burr M. M. Nutrition classics from The Journal of Biological Chemistry 82:345-67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr Rev 1973;31(8):248-249.
21. Callejas N., Casado M., Diaz-Guerra M., Bosca L. and Martin-Sanz P. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 2001;33:860-867.
22. Chang M. S., Chen B. C., Yu M. T., Sheu J. R., Chen T. F. and Lin C. H. Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways. Cell Signal 2005;17(3):299-310.
23. Chen C. H. and Walterscheid J. P. Plaque angiogenesis versus compensatory arteriogenesis in atherosclerosis. Circ Res 2006;99(8):787-789.
24. Choi Y. A., Lee D. J., Lim H. K., Jeong J. H., Sonn J. K., Kang S. S. and Baek S. H. Interleukin-1beta stimulates matrix metalloproteinase-2 expression via a prostaglandin E2-dependent mechanism in human chondrocytes. Exp Mol Med 2004;36(3):226-232.
25. Cipollone F. and Fazia M. L. COX-2 and atherosclerosis. J Cardiovasc Pharmacol 2006;47 Suppl 1:S26-36.
26. 2-dependent plaque instability. Circulation 2001;104:921-927.
27. Cok S. J. and Morrison A. R. The 3'-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 2001;276(25):23179-23185. Epub 22001 Apr 23179.
28. Connolly J. M., Gilhooly E. M. and Rose D. P. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA- MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer 1999;35(1):44-49.
29. Connor K. M., SanGiovanni J. P., Lofqvist C., Aderman C. M., Chen J., Higuchi A., Hong S., Pravda E. A., Majchrzak S., Carper D., Hellstrom A., Kang J. X., Chew E. Y., Salem N., Jr., Serhan C. N. and Smith L. E. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007;13(7):868-873.
30. Cooke J. P. and Bitterman H. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med 2004;36(1):33-40.
31. 2 and matrix metalloproteinase production by human monocytes. Arch Biochem Biophys 1994;310:481-488.
32. Cybulsky M. J., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V. M., Gutierrez-Ramos J.-C., Connelly P. W. and Milstone D. S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255-1262.
33. Das U. N. Essential Fatty acids - a review. Curr Pharm Biotechnol 2006;7(6):467-482.
34. De Caterina R. Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Clin Nutr Metab Care. 2000;3(6):453-467.
35. De Caterina R., Bernini W., Carluccio M., Liao J. and Libby P. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res 1998;39:1062-1070.
36. De Caterina R., Cybulsky M. A., Clinton S. K., Gimbrone M. A. J. r. and Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostagl Leukotr Ess Fatty Acids 1995;52:191-195.
37. De Caterina R., Cybulsky M. I., Clinton S. K., Gimbrone M. A. and Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb Vasc Biol 1994;14:1829-1836.
38. De Caterina R. and Gimbrone M. A. J. r. Leukocyte-endothelial interactions and the pathogenesis of atherosclerosis. In: Kristensen S. D., Schmidt E. B., De Caterina R., Endres S., editors. n-3 Fatty Acids - Prevention and Treatment in Vascular Disease. London: Springer Verlag; 1995. p. 9-24.
39. De Caterina R., Madonna R., Hassan J. and Procopio A. D. Nutrients and gene expression. World Rev Nutr Diet 2001;89:23-52.
40. De Caterina R., Massaro M. and Libby P., editors. Endothelial functions and dysfunctions. Singapore: Blackwall Publishing; 2007.
41. De Caterina R., Zampolli A., Del Turco S., Madonna R. and Massaro M. Nutritional mechanisms that influence cardiovascular disease. Am J Clin Nutr 2006;83(2):421S-426S.
42. Department of health. Nutritional aspect of cardiovascular disease: report of the cardiovascular review group. In: policy C. o. m. a. o. o. f., editor. HMSO; 1994; London; 1994.
43. Desvregne B. and Wahli W. Peroxisome proliferator-activated receptor: nuclear control of metabolism. Endocrine Rev 1999;20(5):649-688.
44. Dimmeler S. and Zeiher A. M. Akt takes center stage in angiogenesis signaling. Circ Res 2000;86(1):4-5.
45. Dolecek T. A. and Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 1991;66:205-216.
46. Dormond O., Bezzi M., Mariotti A. and Ruegg C. Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling. J Biol Chem 2002;277(48):45838-45846.
47. Dormond O., Foletti A., Paroz C. and Ruegg C. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat Med 2001;7(9):1041-1047.
48. Dorn G. W., 2nd, Becker M. W. and Davis M. G. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem 1992;267(34):24897-24905.
49. Doyle B. and Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol 2007;49(21):2073-2080.
50. Dunmore B. J., McCarthy M. J., Naylor A. R. and Brindle N. P. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. J Vasc Surg 2007;45(1):155-159.
51. Dyerberg J., Bang H. O. and Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975;28(9):958-966.
52. Eritsland J., Arnesen H., Grønseth K., Field N. B. and Abdelnoor M. Effect of supplementation with n-3 fatty acids on graft patency in patients undergoing coronary artery bypass operation. Results from the SHOT study. Eur Heart J 15:29 (Abstract 351) 1994.
53. Freeman B. A., Baker P. R., Schopfer F. J., Woodcock S. R., Napolitano A. and d'Ischia M. Nitro-fatty acid formation and signaling. J Biol Chem 2008:1-16.
54. Gately S. and Li W. W. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 2004;31(2 Suppl 7):2-11.
55. Geiringer E. Intimal vascularization and atherosclerosis. J Pathol Bacteriol 1951;63(2):201-211.
56. Gilbert M., Dalloz S., Maclouf J. and Lagarde M. Differential effects of long chain n-3 fatty acids on the expression of PGH synthase isoforms in bovine aortic endothelial cells. Prostaglandins Leukot Essent Fatty Acids 1999;60(5-6):363-365.
57. Guan Z., Buckman S. Y., Pentland A. P., Templeton D. J. and Morrison A. R. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway. J Biol Chem 1998;273(21):12901-12908.
58. Hahn G. L. and Polgar P. R. Prostaglandin production in phenotypically distinct cultured bovine pulmonary artery endothelium. Atherosclerosis. 1984;51(1):143-150.
59. Harris M. A., Hansen R. A., Vidsudhiphan P., Koslo J. L., Thomas J. B., Watkins B. A. and Allen K. G. Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production. Prostaglandins Leukot Essent Fatty Acids 2001;65(1):23-29.
60. Harris W. S. The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep 2006;8(6):453-459.
61. Harris W. S., Assaad B. and Poston W. C. Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease. Am J Cardiol 2006;98(4A):19i-26i.
62. Harris W. S., Poston W. C. and Haddock C. K. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007;193(1):1-10.
63. Hayden M. S. and Ghosh S. Signaling to NF-kappaB. Genes Dev 2004;18(18):2195-2224.
64. Henderson R. and Sargent J. Chain-length specificities of mitochondrial and peroxisomal beta-oxidation of fatty acids in livers of rainbow trout (Salmo gairdneri). Comp Biochem Physiol 1985;82B:79-85.
65. Herrmann J., Lerman L. O., Rodriguez-Porcel M., Holmes D. R., Jr., Richardson D. M., Ritman E. L. and Lerman A. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 2001;51(4):762-766.
66. Hirai K., Ezumi Y., Nishida E., Uchiyama T. and Takayama H. Comparative study of vanadate- and phorbol ester-induced cyclo-oxygenase-2 expression in human endothelial cells. Thromb Haemost 1999;82(5):1545-1552.
67. Hirota K. and Semenza G. L. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 2006;59(1):15-26.
68. Hla T. and Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-7388.
69. Hong. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions. Yonsei Med J 2000;41:82-88.
70. Hunter D. J., Kazda I., Chockalingam A. and Fodor J. G. Fish consumption and cardiovascular mortality in Canada: an inter-regional comparison. Am J Prev Med 1988;4(1):5-10.
71. Huttner J. J., Gwebu E. T., Panganamala R. V., Milo G. E., Cornwell D. C., Sharma H. M. and Geer J. C. Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells. Science 1977;197(4300):289-291.
72. Inoue I., Shino K., Noji S., Awata T. and Katayama S. Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells. Biochem Biophys Res Commun 1998;246(2):370-374.
73. Issemann I. and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347(6294):645-650.
74. Jones M. K., Wang H., Peskar B. M., Levin E., Itani R. M., Sarfeh I. J. and Tarnawski A. S. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999;5(12):1418-1423.
75. Jude S., Roger S., Martel E., Besson P., Richard S., Bougnoux P., Champeroux P. and Le Guennec J. Y. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol 2006;90(1-3):299-325.
76. Kanayasu T., Morita I., Nakao-Hayashi J., Asuwa N., Fujisawa C., Ishii T., Ito H. and Murota S. Eicosapentaenoic acid inhibits tube formation of vascular endothelial cells in vitro. Lipids 1991;26(4):271-276.
77. Kang J. X. The importance of omega-6/omega-3 fatty acid ratio in cell function. The gene transfer of omega-3 fatty acid desaturase. World Rev Nutr Diet 2003;92:23-36.
78. Kang J. X., Wang J., Wu L. and Kang Z. B. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004;427(6974):504.
79. Khatri J. J., Johnson C., Magid R., Lessner S. M., Laude K. M., Dikalov S. I., Harrison D. G., Sung H. J., Rong Y. and Galis Z. S. Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 2004;109(4):520-525.
80. Kromhout D., Bosschieter E. B. and De Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-1209.
81. Kumamoto M., Nakashima Y. and Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995;26(4):450-456.
82. Kuwahara F., Kai H., Tokuda K., Shibata R., Kusaba K., Tahara N., Niiyama H., Nagata T. and Imaizumi T. Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension 2002;39(1):46-50.
83. Kuwashima L., Graeber J. and Glaser B. M. Stimulation of endothelial cell prostacyclin release by retina-derived factors. Invest Ophthalmol Vis Sci. 1988;29(8):1213-1220.
84. Kwon H. M., Sangiorgi G., Ritman E. L., McKenna C., Holmes D. R., Jr., Schwartz R. S. and Lerman A. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998;101(8):1551-1556.
85. Leahy K., Koki A. and Masferrer J. Role of cyclooxygenase in angiogenesis. Curr Med Chem 2000;7:1163-1170.
86. Lee J. Y., Plakidas A., Lee W. H., Heikkinen A., Chanmugam P., Bray G. and Hwang D. H. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003;44(3):479-486. Epub 2002 Dec 2001.
87. Lee J. Y., Ye J., Gao Z., Youn H. S., Lee W. H., Zhao L., Sizemore N. and Hwang D. H. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003;278(39):37041-37051. Epub 32003 Jul 37015.
88. Li Q. and Engelhardt J. F. Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase. J Biol Chem 2006;281(3):1495-1505.
89. Li R. C., Ping P., Zhang J., Wead W. B., Cao X., Gao J., Zheng Y., Huang S., Han J. and Bolli R. PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 2000;279(4):H1679-1689.
90. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003;91 (suppl):3A-6A.
91. Linares F. and Henderson R. Incorporation of 14C-labelled polyunsaturated fatty acids by juvenile turbot, Scophthalmus maximus (L.) in vivo. J Fish Biol 1991; 38:335-347.
92. Liu C. H., Chang S. H., Narko K., Trifan O. C., Wu M. T., Smith E., Haudenschild C., Lane T. F. and Hla T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001;276(21):18563-18569.
93. Liu X. H., Kirschenbaum A., Lu M., Yao S., Dosoretz A., Holland J. F. and Levine A. C. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. J Biol Chem. 2002;277(51):50081-50086. Epub 52002 Oct 50024.
94. Ma D. W., Seo J., Switzer K. C., Fan Y. Y., McMurray D. N., Lupton J. R. and Chapkin R. S. n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 2004;15(11):700-706.
95. Madonna R. and De Caterina R. Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling. Thromb Haemost 2009;101(2):345-350.
96. Marx N., Duez H., Fruchart J. C. and Staels B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 2004;94(9):1168-1178.
97. Marx N., Sukhova G. K., Collins T., Libby P. and Plutzky J. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 1999;99(24):3125-3131.
98. Massaro M., Basta G., Lazzerini G., Carluccio M., Bosetti F., Solaini G., Visioli F., Paolicchi A. and De Caterina R. Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis. Thromb Haemost 2002;88:176-375.
99. Massaro M., Habib A., Lubrano L., Del Turco S., Lazzerini G., Bourcier T., Weksler B. B. and De Caterina R. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCepsilon inhibition. Proc Natl Acad Sci U S A 2006;103(41):15184-15189.
100. Massaro M., Scoditti E., Carluccio M. A. and De Caterina R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot Essent Fatty Acids 2008;79(3-5):109-115.
101. McCarthy M. J., Loftus I. M., Thompson M. M., Jones L., London N. J., Bell P. R., Naylor A. R. and Brindle N. P. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 1999;30(2):261-268.
102. Mishra A., Chaudhary A. and Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway. Arterioscler Thromb Vasc Biol 2004;24(9):1621-1627.
103. Mofidi R., Crotty T. B., McCarthy P., Sheehan S. J., Mehigan D. and Keaveny T. V. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg 2001;88(7):945-950.
104. Morris M. C., Manson J. E., Rosner B., Buring J. E., Willett W. C. and Hennekens C. H. Fish consumption and cardiovascular disease in the physicians' health study: a prospective study. Am J Epidemiol 1995;142(2):166-175.
105. Moulton K. S. Plaque angiogenesis: its functions and regulation. Cold Spring Harb Symp Quant Biol 2002;67:471-482.
106. Moulton K. S., Heller E., Konerding M. A., Flynn E., Palinski W. and Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999;99(13):1726-1732.
107. Murohara T., Horowitz J. R., Silver M., Tsurumi Y., Chen D., Sullivan A. and Isner J. M. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998;97(1):99-107.
108. Newman W. P., Middaugh J. P., Propst M. T. and Rogers D. R. Atherosclerosis in Alaska natives and non-natives. Lancet 1993;341:1056-1057.
109. Nordoy A. and Goodnight S. H. Dietary lipids and thrombosis. Relationships to atherosclerosis. Arteriosclerosis 1990;10(2):149-163.
110. Norell S. E., Ahlbom A., Feichting M. and Pedersen N. L. Fish consumption and mortality from heart disease. Br Med J 1986;283:426.
111. O'Brien K. D., Allen M. D., McDonald T. O., Chait A., Harlan J. M., Fishbein D., McCarty J., Ferguson M., Hudkins K., Benjamin C. D. and et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993;92(2):945-951.
112. O'Brien K. D., McDonald T. O., Chait A., Allen M. D. and Alpers C. E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93(4):672-682.
113. Okon E. B., Szado T., Laher I., McManus B. and van Breemen C. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 2003;40(6):520-530.
114. Pahl H. and Baeuerle P. A. Oxygen and the control of gene expression. Bioessays 1994;16:479-501.
115. Pai R., Soreghan B., Szabo I. L., Pavelka M., Baatar D. and Tarnawski A. S. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002;8(3):289-293.
116. Pavlovic S., Du B., Sakamoto K., Khan K. M., Natarajan C., Breyer R. M., Dannenberg A. J. and Falcone D. J. Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J Biol Chem. 2006;281(6):3321-3328. Epub 2005 Dec 3327.
117. Pratico D., Tillmann C., Zhang Z. B., Li H. and FitzGerald G. A. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci U S A 2001;98(6):3358-3363. Epub 2001 Mar 3356.
118. Ramsay R., Ciznadija M., Vanevski M. and Mantamadiotis T. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control. Int J Immunopathol Pharmacol 2003;16:59-67.
119. Rankin E. B., Yu D., Jiang J., Shen H., Pearce E. J., Goldschmidt M. H., Levy D. E., Golovkina T. V., Hunter C. A. and Thomas-Tikhonenko A. An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth. Cancer Biol Ther. 2003;2(6):687-693.
120. Ray R. and Shah A. M. NADPH oxidase and endothelial cell function. Clin Sci (Lond) 2005;109(3):217-226.
121. Rikitake Y., Hirata K., Kawashima S., Takeuchi S., Shimokawa Y., Kojima Y., Inoue N. and Yokoyama M. Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine. Biochem Biophys Res Commun 2001;281(5):1291-1297.
122. Rose D. P. and Connolly J. M. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int J Oncol 1999;15(5):1011-1015.
123. Rose D. P., Connolly J. M. and Coleman M. Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin Cancer Res 1996;2(10):1751-1756.
124. Ross R. Atherosclerosis - An inflammatory disease. N. Engl. J. Med. 1999;340(2):115-126.
125. Rott D., Zhu J., Burnett M. S., Zhou Y. F., Zalles-Ganley A., Ogunmakinwa J. and Epstein S. E. Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice. J Am Coll Cardiol 2003;41(10):1812-1819.
126. Rueckschloss U., Duerrschmidt N. and Morawietz H. NADPH oxidase in endothelial cells: impact on atherosclerosis. Antioxid Redox Signal 2003;5(2):171-180.
127. Schönbeck U., Sukkova G., Graber P., Coulter S. and Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 1999;155:1281-1291.
128. Schwacha M. G., Chung C. S., Ayala A., Bland K. I. and Chaudry I. H. Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury. Am J Physiol Cell Physiol 2002;282(2):C263-270.
129. Serhan C. N. and Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 2008;153 Suppl 1:S200-215.
130. Sethi S., Ziouzenkova O., Ni H., Wagner D. D., Plutzky J. and Mayadas T. N. Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPAR alpha. Blood 2002;100(4):1340-1346.
131. Shimokawa H. and Vanhoutte P. M. Dietary omega 3 fatty acids and endothelium-dependent relaxations in porcine coronary arteries. Am J Physiol 1989;256(4 Pt 2):H968-973.
132. Sima A. V., Stancu C. S. and Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res 2009;335(1):191-203.
133. Simopoulos A. P. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54(3):438-463.
134. Simopoulos A. P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56(8):365-379.
135. Simopoulos A. P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006;60(9):502-507.
136. Sinclair H. M. Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet 1956;270(6919):381-383.
137. Smith W. L., Garavito R. M. and DeWitt D. L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271(52):33157-33160.
138. Soei L., Lamers J., Sassen L., van Tol A., Scheek L., Dekkers D., van Meegen J. and Verdouw P. Fish oil: a modulator of experimental atherosclerosis in animals. In: Kristensen S., Endres S., De Caterina R., Schmidt E., editors. n-3 Fatty Acids: Prevention and Treatment in Vascular Disease. London: Springer; 1995. p. 77-84.
139. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 2000;1486(2-3):219-231.
140. Stacy Z. A., Dobesh P. P. and Trujillo T. C. Cardiovascular risks of cyclooxygenase inhibition. Pharmacotherapy. 2006;26(7):919-938.
141. Stemme V., Swedenborg J., Claesson H. and Hansson G. K. Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg 2000;20(2):146-152.
142. Stillwell W., Shaikh S. R., Zerouga M., Siddiqui R. and Wassall S. R. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 2005;45(5):559-579.
143. Suzuki I., Iigo M., Ishikawa C., Kuhara T., Asamoto M., Kunimoto T., Moore M. A., Yazawa K., Araki E. and Tsuda H. Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int J Cancer 1997;73(4):607-612.
144. Szymczak M., Murray M. and Petrovic N. Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood 2008;111(7):3514-3521.
145. Tanabe T. and Tohnai N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 2002;68-69:95-114.
146. Thies F., Garry J. M., Yaqoob P., Rerkasem K., Williams J., Shearman C. P., Gallagher P. J., Calder P. C. and Grimble R. F. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003;361(9356):477-485.
147. Tocher D. and Sargent J. Effect of temperature on the incorporation into phospholipid classes and metabolism via desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids in fish cells in culture. Lipids 1990;25:435-442.
148. Tontonoz P., Hu E., Graves R. A., Budavari A. I. and Spiegelman B. M. mPpar gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994;8(10):1224-1234.
149. Touyz R. M. and Schiffrin E. L. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vascul Pharmacol 2006;45(1):19-28.
150. Tsuji M., Murota S. I. and Morita I. Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot Essent Fatty Acids 2003;68(5):337-342.
151. Tsurumi Y., Murohara T., Krasinski K., Chen D., Witzenbichler B., Kearney M., Couffinhal T. and Isner J. M. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997;3(8):879-886.
152. Tsuzuki T., Shibata A., Kawakami Y., Nakagawa K. and Miyazawa T. Conjugated eicosapentaenoic acid inhibits vascular endothelial growth factor-induced angiogenesis by suppressing the migration of human umbilical vein endothelial cells. J Nutr 2007;137(3):641-646.
153. Vancov V. Structural basis of the microcirculation in the wall of arterial vessels. Bibl Anat 1973;11:383-388.
154. Virmani R., Kolodgie F. D., Burke A. P., Finn A. V., Gold H. K., Tulenko T. N., Wrenn S. P. and Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25(10):2054-2061.
155. Wahli W., Braissant O. and Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more... Chem Biol 1995;2(5):261-266.
156. Wang L. H., Hajibeigi A., Xu X. M., Loose-Mitchell D. and Wu K. K. Characterization of the promoter of human prostaglandin H synthase-1 gene. Biochem Biophys Res Commun 1993;190(2):406-411.
157. Wijendran V. and Hayes K. C. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 2004;24:597-615.
158. Winternitz M., Thomas R. and LeCompte P. The biology of atherosclerosis. Springfield; 1938.
159. Wohlfeil E. R. and Campbell W. B. 25-hydroxycholesterol increases eicosanoids and alters morphology in cultured pulmonary artery smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 1999;19(12):2901-2908.
160. Wong S. T., Baker L. P., Trinh K., Hetman M., Suzuki L. A., Storm D. R. and Bornfeldt K. E. Adenylyl cyclase 3 mediates prostaglandin E(2)-induced growth inhibition in arterial smooth muscle cells. J Biol Chem. 2001;276(36):34206-34212. Epub 32001 Jun 34229.
161. Yamazaki K., Fujikawa M., Hamazaki T., Yano S. and Shono T. Comparison of the conversion rates of alpha-linolenic acid (18:3(n - 3)) and stearidonic acid (18:4(n - 3)) to longer polyunsaturated fatty acids in rats. Biochim Biophys Acta 1992;1123(1):18-26.
162. Yano K., MacLean C. J., Reed D. M., Shimizu Y., Sasaki H., Kodama K., Kato H. and Kagan A. A comparison of the 12-year mortality and predictive factors of coronary heart disease among Japanese men in Japan and Hawaii. Am J Epidemiol 1988;127(3):476-487.
163. Yuan J. M., Ross R. K., Gao Y. T. and Yu M. C. Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol 2001;154(9):809-816.
164. Ziouzenkova O. and Plutzky J. Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation? Curr Opin Clin Nutr Metab Care 2004;7(4):369-375.
165. Andersen, V.L., Vogt, J., Obel, T., Christensen, J.H., Schmidt, E.B., The effect of n-3 fatty acids on plasma myeloperoxidase levels in healthy adults. Cell. Mol. Biol. 2010, 56(1): 3-9.
166. Andreasen, J. J., Aardestrup, I. V., Eschen, R. B., Obel, T., Lundbye-Christensen, S., Schmidt, E. B., Fatty acid composition of the internal mammary artery in relation to dietary intake of marine n-3 polyunsaturated fatty acids and association with flow-mediated vasodilation. Cell. Mol. Biol. 2010, 56(1): 10-17.
167. Arnesen, H., Seljeflot, I., Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation. Cell. Mol. Biol. 2010, 56(1): 18-27.
168. Calder, P.C., Yaqoob, P., Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell. Mol. Biol. 2010, 56(1): 28-37.
169. Petersen, M.M., Eschen, R.B., Aardestrup, I., Obel, T., Schmidt, E.B., Flow-mediated vasodilation and dietary intake of n-3 polyunsaturated acids in healthy subjects. Cell. Mol. Biol. 2010, 56(1): 38-44.
170. Eschen, O., Christensen, J.H., La rovere, M.T., Romano, P., Sala, P., Schmidt, E.B., Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Cell. Mol. Biol. 2010, 56(1): 45-51.
171. Isherwood, C, Wong, M., Jones, W.S., Davies, I.G., Griffin, B.A., lack of effect of cold water prawns on plasma cholesterol and lipoproteins in normo-lipidaemic men. Cell. Mol. Biol. 2010, 56(1): 52-58.
172. Mori, T. A., Omega-3 fatty acids and blood pressure. Cell. Mol. Biol. 2010, 56(1): 83-92.
173. Von Schacky, C, Omega-3 fatty acids vs. cardiac disease - the contribution of the omega-3 index. Cell. Mol. Biol. 2010, 56(1): 93-101.
174. 2-macroglobulin in healthy subjects after supplementation with different doses of marine n-3 fatty acids. Cell. Mol. Biol. 2010, 56(1): 102-109.
175. Marchioli, R., Silletta, M.G., Levantesi, G., Pioggiarella, R., Tognoni, G., N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence. Cell. Mol. Biol. 2010, 56(1): 110-130.
176. Christensen, J.H., Svensson, M., Strandhave, C, Madsen, T., Schmidt, E.B., N-3 fatty acids and cardiac autonomic function in humans. Cell. Mol. Biol. 2010, 56(1): 131-139.